Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia

Pyeonghwa Jeong, Yeongyu Moon, Je Heon Lee, So Deok Lee, Jiyeon Park, Jungeun Lee, Jiheon Kim, Hyo Jeong Lee, Na Yoon Kim, Jungil Choi, Jeong Doo Heo, Ji Eun Shin, Hyun Woo Park, Yoon Gyoon Kim, Sun Young Han, Yong Chul Kim

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science